1p13.2 deletion displays clinical features overlapping noonan syndrome, likely related to NRAS gene haploinsufficiency

Natália Duarte Linhares, Maíra Cristina Menezes Freire, Raony Guimarães Corrêa do Carmo Lisboa Cardenas, Heloisa Barbosa Pena, Katherine Lachlan, Bruno Dallapiccola, Carlos Bacino, Bruno Delobel, Paul James, Ann Charlotte Thuresson, Göran Annerén, Sérgio D J Pena

Research output: Contribution to journalArticle

Abstract

Deletion-induced hemizygosity may unmask deleterious autosomal recessive variants and be a cause of the phenotypic variability observed in microdeletion syndromes. We performed complete exome sequencing (WES) analysis to examine this possibility in a patient with 1p13.2 microdeletion. Since the patient displayed clinical features suggestive of Noonan Syndrome (NS), we also used WES to rule out the presence of pathogenic variants in any of the genes associated with the different types of NS. We concluded that the clinical findings could be attributed solely to the 1p13.2 haploinsufficiency. Retrospective analysis of other nine reported patients with 1p13.2 microdeletions showed that six of them also presented some characteristics of NS. In all these cases, the deleted segment included the NRAS gene. Gain-of-function mutations of NRAS gene are causally related to NS type 6. Thus, it is conceivable that NRAS haploinsufficiency and gain-of-function mutations may have similar clinical consequences. The same phenomenon has been described for two other genes belonging to the Ras/MAPK pathway: MAP2K2 and SHOC2. In conclusion, we here report genotype-phenotype correlations in patients with chromosome 1p13.2 microdeletions and we propose that NRAS may be a critical gene for the NS characteristics in the patients.

Original languageEnglish
Pages (from-to)349-357
Number of pages9
JournalGenetics and Molecular Biology
Volume39
Issue number3
DOIs
Publication statusPublished - Jul 1 2016

Fingerprint

Noonan Syndrome
Haploinsufficiency
Genes
Exome
Mutation
Genetic Association Studies
Chromosomes

Keywords

  • 1p13.2 deletion
  • Noonan syndrome type 6
  • NRAS gene
  • RASopathy
  • Unmasking heterozygosity

ASJC Scopus subject areas

  • Molecular Biology
  • Genetics

Cite this

1p13.2 deletion displays clinical features overlapping noonan syndrome, likely related to NRAS gene haploinsufficiency. / Linhares, Natália Duarte; Freire, Maíra Cristina Menezes; Cardenas, Raony Guimarães Corrêa do Carmo Lisboa; Pena, Heloisa Barbosa; Lachlan, Katherine; Dallapiccola, Bruno; Bacino, Carlos; Delobel, Bruno; James, Paul; Thuresson, Ann Charlotte; Annerén, Göran; Pena, Sérgio D J.

In: Genetics and Molecular Biology, Vol. 39, No. 3, 01.07.2016, p. 349-357.

Research output: Contribution to journalArticle

Linhares, ND, Freire, MCM, Cardenas, RGCDCL, Pena, HB, Lachlan, K, Dallapiccola, B, Bacino, C, Delobel, B, James, P, Thuresson, AC, Annerén, G & Pena, SDJ 2016, '1p13.2 deletion displays clinical features overlapping noonan syndrome, likely related to NRAS gene haploinsufficiency', Genetics and Molecular Biology, vol. 39, no. 3, pp. 349-357. https://doi.org/10.1590/1678-4685-GMB-2016-0049
Linhares, Natália Duarte ; Freire, Maíra Cristina Menezes ; Cardenas, Raony Guimarães Corrêa do Carmo Lisboa ; Pena, Heloisa Barbosa ; Lachlan, Katherine ; Dallapiccola, Bruno ; Bacino, Carlos ; Delobel, Bruno ; James, Paul ; Thuresson, Ann Charlotte ; Annerén, Göran ; Pena, Sérgio D J. / 1p13.2 deletion displays clinical features overlapping noonan syndrome, likely related to NRAS gene haploinsufficiency. In: Genetics and Molecular Biology. 2016 ; Vol. 39, No. 3. pp. 349-357.
@article{112c3ad668e74ec8877c69d552a1c1f5,
title = "1p13.2 deletion displays clinical features overlapping noonan syndrome, likely related to NRAS gene haploinsufficiency",
abstract = "Deletion-induced hemizygosity may unmask deleterious autosomal recessive variants and be a cause of the phenotypic variability observed in microdeletion syndromes. We performed complete exome sequencing (WES) analysis to examine this possibility in a patient with 1p13.2 microdeletion. Since the patient displayed clinical features suggestive of Noonan Syndrome (NS), we also used WES to rule out the presence of pathogenic variants in any of the genes associated with the different types of NS. We concluded that the clinical findings could be attributed solely to the 1p13.2 haploinsufficiency. Retrospective analysis of other nine reported patients with 1p13.2 microdeletions showed that six of them also presented some characteristics of NS. In all these cases, the deleted segment included the NRAS gene. Gain-of-function mutations of NRAS gene are causally related to NS type 6. Thus, it is conceivable that NRAS haploinsufficiency and gain-of-function mutations may have similar clinical consequences. The same phenomenon has been described for two other genes belonging to the Ras/MAPK pathway: MAP2K2 and SHOC2. In conclusion, we here report genotype-phenotype correlations in patients with chromosome 1p13.2 microdeletions and we propose that NRAS may be a critical gene for the NS characteristics in the patients.",
keywords = "1p13.2 deletion, Noonan syndrome type 6, NRAS gene, RASopathy, Unmasking heterozygosity",
author = "Linhares, {Nat{\'a}lia Duarte} and Freire, {Ma{\'i}ra Cristina Menezes} and Cardenas, {Raony Guimar{\~a}es Corr{\^e}a do Carmo Lisboa} and Pena, {Heloisa Barbosa} and Katherine Lachlan and Bruno Dallapiccola and Carlos Bacino and Bruno Delobel and Paul James and Thuresson, {Ann Charlotte} and G{\"o}ran Anner{\'e}n and Pena, {S{\'e}rgio D J}",
year = "2016",
month = "7",
day = "1",
doi = "10.1590/1678-4685-GMB-2016-0049",
language = "English",
volume = "39",
pages = "349--357",
journal = "Genetics and Molecular Biology",
issn = "1415-4757",
publisher = "Brazilian Society of Genetics",
number = "3",

}

TY - JOUR

T1 - 1p13.2 deletion displays clinical features overlapping noonan syndrome, likely related to NRAS gene haploinsufficiency

AU - Linhares, Natália Duarte

AU - Freire, Maíra Cristina Menezes

AU - Cardenas, Raony Guimarães Corrêa do Carmo Lisboa

AU - Pena, Heloisa Barbosa

AU - Lachlan, Katherine

AU - Dallapiccola, Bruno

AU - Bacino, Carlos

AU - Delobel, Bruno

AU - James, Paul

AU - Thuresson, Ann Charlotte

AU - Annerén, Göran

AU - Pena, Sérgio D J

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Deletion-induced hemizygosity may unmask deleterious autosomal recessive variants and be a cause of the phenotypic variability observed in microdeletion syndromes. We performed complete exome sequencing (WES) analysis to examine this possibility in a patient with 1p13.2 microdeletion. Since the patient displayed clinical features suggestive of Noonan Syndrome (NS), we also used WES to rule out the presence of pathogenic variants in any of the genes associated with the different types of NS. We concluded that the clinical findings could be attributed solely to the 1p13.2 haploinsufficiency. Retrospective analysis of other nine reported patients with 1p13.2 microdeletions showed that six of them also presented some characteristics of NS. In all these cases, the deleted segment included the NRAS gene. Gain-of-function mutations of NRAS gene are causally related to NS type 6. Thus, it is conceivable that NRAS haploinsufficiency and gain-of-function mutations may have similar clinical consequences. The same phenomenon has been described for two other genes belonging to the Ras/MAPK pathway: MAP2K2 and SHOC2. In conclusion, we here report genotype-phenotype correlations in patients with chromosome 1p13.2 microdeletions and we propose that NRAS may be a critical gene for the NS characteristics in the patients.

AB - Deletion-induced hemizygosity may unmask deleterious autosomal recessive variants and be a cause of the phenotypic variability observed in microdeletion syndromes. We performed complete exome sequencing (WES) analysis to examine this possibility in a patient with 1p13.2 microdeletion. Since the patient displayed clinical features suggestive of Noonan Syndrome (NS), we also used WES to rule out the presence of pathogenic variants in any of the genes associated with the different types of NS. We concluded that the clinical findings could be attributed solely to the 1p13.2 haploinsufficiency. Retrospective analysis of other nine reported patients with 1p13.2 microdeletions showed that six of them also presented some characteristics of NS. In all these cases, the deleted segment included the NRAS gene. Gain-of-function mutations of NRAS gene are causally related to NS type 6. Thus, it is conceivable that NRAS haploinsufficiency and gain-of-function mutations may have similar clinical consequences. The same phenomenon has been described for two other genes belonging to the Ras/MAPK pathway: MAP2K2 and SHOC2. In conclusion, we here report genotype-phenotype correlations in patients with chromosome 1p13.2 microdeletions and we propose that NRAS may be a critical gene for the NS characteristics in the patients.

KW - 1p13.2 deletion

KW - Noonan syndrome type 6

KW - NRAS gene

KW - RASopathy

KW - Unmasking heterozygosity

UR - http://www.scopus.com/inward/record.url?scp=84984843673&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84984843673&partnerID=8YFLogxK

U2 - 10.1590/1678-4685-GMB-2016-0049

DO - 10.1590/1678-4685-GMB-2016-0049

M3 - Article

AN - SCOPUS:84984843673

VL - 39

SP - 349

EP - 357

JO - Genetics and Molecular Biology

JF - Genetics and Molecular Biology

SN - 1415-4757

IS - 3

ER -